Sepsis & infection

Early trajectories of antibiotic exposure and colonization pressure and risk of ICU-acquired carbapenem-resistant Gram-negative bacteria: A prospective cohort study

Ann Intensive CarePublished Prospective cohort study

Authors' conclusion

This study identified distinct early trajectories of antibiotic exposure and colonization pressure that were associated with differential CR-GNB acquisition risk.

Study context

Population
Consecutive ICU patients with systematic rectal surveillance cultures, four intensive care units (ICUs) of a tertiary-care center in China, March 2024 to January 2025Day-5 landmark analysis
Participants
533 patients
Exposure
Early joint trajectories of antibiotic exposure and colonization pressure (first 5 ICU days): escalating exposure/intermediate pressure and high exposure/high pressure vs low exposure/low pressure
Outcome
ICU-acquired carbapenem-resistant Gram-negative bacteria (CR-GNB)
Follow-up
After Day 5
Methodological detailsgroup-based multi-trajectory modeling, continuous-time Markov multi-state models, Day-5 landmark analysis, four ICUs, single tertiary-care centre
  • Group-based multi-trajectory modeling
  • Continuous-time Markov multi-state models
  • Day-5 landmark analysis
  • Four ICUs, single tertiary-care centre

Main finding

As reported in the abstract

ICU-acquired CR-GNB after the Day-5 landmark
Adjusted hazard ratio (95% CI)P value
Escalating-exposure vs Low-exposure
1.68(1.24–2.28)
P < 0.001
High-exposure vs Low-exposure
2.82(1.53–5.19)
P < 0.001
Overall Carbapenem-resistant Gram-negative bacteria (CR-GNB) acquisition
124 (23.3%)

Observational data: associations, not effects.

Original publication

Early trajectories of antibiotic exposure and colonization pressure and risk of ICU-acquired carbapenem-resistant Gram-negative bacteria: A prospective cohort study. Ann Intensive Care. Published 6 April 2026. doi:10.1016/j.aicoj.2026.100063

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.